CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Boya Bio-pharmaceutical Group Co Ltd Company Snapshot
Boya Bio-pharmaceutical Group Co Ltd operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Boya Bio-pharmaceutical Group Co Ltd with three other companies in this sector in China: Beijing SL Pharmaceutical Co Ltd (2016 sales of 1.01 billion Chinese Renmimbi [US$152.57 million] of which 98% was Pharmaceuticals Industry), Walvax Biotechnology Company Limited (590.16 million Chinese Renmimbi [US$89.16 million] of which 38% was Autonomous Vaccine), and Tianjin Ringpu Bio-Technology Co Ltd (969.68 million Chinese Renmimbi [US$146.50 million] of which 63% was Veterinary Biological Products).

Sales Analysis. Boya Bio-pharmaceutical Group Co Ltd reported sales of 946.57 million Chinese Renmimbi (US$143.01 million) for the year ending December of 2016. This represents an increase of 74.3% versus 2015, when the company's sales were 543.10 million Chinese Renmimbi. Sales at Boya Bio-pharmaceutical Group Co Ltd have increased during each of the previous five years (and since 2011, sales have increased a total of 381%). Sales of Bio-Pharmaceuticals saw an increase that was more than double the company's growth rate: sales were up 1,065.6% in 2016, from 18.56 million Chinese Renmimbi to 216.29 million Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Boya Bio-pharmaceutical Group Co Ltd
  Stock Performance Chart for Boya Bio-pharmaceutical Group Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 30.99
(Figures in Chinese Renmimbi)
1 Week 0.3%   13 Weeks -8.7%  
4 Weeks -13.6%   52 Weeks -20.6%  
 
Boya Bio-pharmaceutical Group Co Ltd Key Data:
  Ticker: 300294 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 946,570,683
(Year Ending Jan 2017).
Employees: 1,365
  Currency: Chinese Renmimbi Market Cap: 12,429,382,459
  Fiscal Yr Ends: December Shares Outstanding: 401,077,201
  Share Type: A Gu Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.